Akero Therapeutics: Deceptively Promising
Seeking Alpha,
Summary Akero Therapeutics is a deceptively promising long at these levels. EFX still has to jump through clinical trials and…
Summary Akero Therapeutics is a deceptively promising long at these levels. EFX still has to jump through clinical trials and…
Share on Pinterest New research suggests a new treatment pathway for type 2 diabetes.
Are junk food manufacturers partly responsible for the swelling obesity epidemic that’s shortening lives, or is the onus on us?
The obesity epidemic has helped usher in a non-alcoholic steatohepatitis crisis.
– AJMC Staff September 26, 2019 – AJMC Staff September 26, 2019 – Laura Joszt September 21, 2019 – Laura Joszt September 20…
Previous work has linked psoriasis and non-alcoholic fatty liver disease, but this is one of the first studies to tie together…